306 related articles for article (PubMed ID: 22433828)
21. Emerging techniques and technologies in brain tumor imaging.
Ellingson BM; Bendszus M; Sorensen AG; Pope WB
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii12-23. PubMed ID: 25313234
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
23. New approaches for imaging tumour responses to treatment.
Brindle K
Nat Rev Cancer; 2008 Feb; 8(2):94-107. PubMed ID: 18202697
[TBL] [Abstract][Full Text] [Related]
24. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
Li D; Patel CB; Xu G; Iagaru A; Zhu Z; Zhang L; Cheng Z
Front Immunol; 2020; 11():592389. PubMed ID: 33193439
[TBL] [Abstract][Full Text] [Related]
25. Neuroimaging in patients with gliomas.
Ullrich RT; Kracht LW; Jacobs AH
Semin Neurol; 2008 Sep; 28(4):484-94. PubMed ID: 18843576
[TBL] [Abstract][Full Text] [Related]
26. Review of imaging techniques in the diagnosis and management of brain metastases.
Lignelli A; Khandji AG
Neurosurg Clin N Am; 2011 Jan; 22(1):15-25, v. PubMed ID: 21109145
[TBL] [Abstract][Full Text] [Related]
27. Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.
Jacobs AH; Winkler A; Dittmar C; Gossman A; Deckert M; Kracht L; Thiel A; Garlip G; Hilker R; Sobesky J; Vollmar S; Kummer C; Graf R; Voges J; Wienhard K; Herholz K; Heiss WD
Technol Cancer Res Treat; 2002 Jun; 1(3):187-204. PubMed ID: 12622512
[TBL] [Abstract][Full Text] [Related]
28. ⁹⁰Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.
Fabbri C; Mattone V; Sarti G; Casi M; De Lauro F; Agostini M; Bartolini N; Bartolomei M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1822-3. PubMed ID: 22872309
[No Abstract] [Full Text] [Related]
29. PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.
Puttick S; Bell C; Dowson N; Rose S; Fay M
Drug Discov Today; 2015 Mar; 20(3):306-17. PubMed ID: 25448762
[TBL] [Abstract][Full Text] [Related]
30. Tumor hypoxia imaging.
Sun X; Niu G; Chan N; Shen B; Chen X
Mol Imaging Biol; 2011 Jun; 13(3):399-410. PubMed ID: 20838906
[TBL] [Abstract][Full Text] [Related]
31. The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours.
Peet AC; Leach MO; Pinkerton CR; Price P; Williams SR; Grundy RG
Pediatr Blood Cancer; 2005 Feb; 44(2):103-13. PubMed ID: 15495214
[TBL] [Abstract][Full Text] [Related]
32. High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.
Valonen PK; Griffin JL; Lehtimäki KK; Liimatainen T; Nicholson JK; Gröhn OH; Kauppinen RA
NMR Biomed; 2005 Jun; 18(4):252-9. PubMed ID: 15884096
[TBL] [Abstract][Full Text] [Related]
33. Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets.
Bi J; Chowdhry S; Wu S; Zhang W; Masui K; Mischel PS
Nat Rev Cancer; 2020 Jan; 20(1):57-70. PubMed ID: 31806884
[TBL] [Abstract][Full Text] [Related]
34. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
[TBL] [Abstract][Full Text] [Related]
35. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.
O'Connor JP; Jackson A; Asselin MC; Buckley DL; Parker GJ; Jayson GC
Lancet Oncol; 2008 Aug; 9(8):766-76. PubMed ID: 18672212
[TBL] [Abstract][Full Text] [Related]
36. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
37. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
38. Imaging of brain tumors: perfusion/permeability.
Thompson G; Mills SJ; Stivaros SM; Jackson A
Neuroimaging Clin N Am; 2010 Aug; 20(3):337-53. PubMed ID: 20708550
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.
Lopci E; Riva M; Olivari L; Raneri F; Soffietti R; Piccardo A; Bizzi A; Navarria P; Ascolese AM; Rudà R; Fernandes B; Pessina F; Grimaldi M; Simonelli M; Rossi M; Alfieri T; Zucali PA; Scorsetti M; Bello L; Chiti A
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1155-1164. PubMed ID: 28110346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
